A Systematic Review of Clinical Practice Guidelines for Age-related Macular Degeneration

References

• Keel S, Evans JR, Block S, et al. Strengthening the integration of eye care into the health system: methodology for the development of the WHO package of eye care interventions. BMJ Open Ophthalmol. 2020;5(1):e000533. doi:10.1136/bmjophth-2020-000533.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Peto T. Current perspective on age-related macular degeneration. Jama. 2020;324(8):794–795. doi:10.1001/jama.2020.5576.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–1159. doi:10.1016/S0140-6736(18)31550-2.
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–116. doi:10.1016/S2214-109X(13)70145-1.
   PubMed Web of Science ®Google Scholar
• Woo SJ, Park KH, Ahn J, et al. Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology. 2012;119(10):2094–2101. doi:10.1016/j.ophtha.2012.04.026.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Liew G, Burlutsky G, Mitchell P. Age-related macular degeneration and 5-year incidence of impaired activities of daily living. Maturitas. 2014;77(3):263–266. doi:10.1016/j.maturitas.2013.12.001.
   PubMed Web of Science ®Google Scholar
• Singh N, Srinivasan S, Muralidharan V, Roy R, J V, Raman R. Prevention of age-related macular degeneration. Asia Pac J Ophthalmol (Phila). 2017;6(6):520–526. doi:10.22608/APO2017416.
   PubMed Web of Science ®Google Scholar
• Wagle AM, Au Eong KG. A decade of progress in the understanding, prevention and treatment of age-related macular degeneration in Singapore. Ann Acad Med Singap. 2015;44(4):116–118.
   PubMed Web of Science ®Google Scholar
• Wallace KS BC, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. IHI. 2012;819–824. doi:10.1145/2110363.2110464.
   Google Scholar
• Consortium ANS The AGREE II Instrument [Electronic version] 2017. www.agreetrust.org/wp-content/uploads/2017/2012/AGREE-II-Users-Manual-and-2023-item-Instrument-2009-Update-2017.pdf. Accessed July 17, 2021. Accessed July 10, 2018
   Google Scholar
• Rauch A, Negrini S, Cieza A. Toward strengthening rehabilitation in health systems: methods used to develop a WHO package of rehabilitation interventions. Arch Phys Med Rehabil. 2019;100(11):2205–2211. doi:10.1016/j.apmr.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Ophthalmology AAo. Age-related macular degeneration preferred practice pattern. 2019. https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp. Accessed July 17, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Aflflibercept solution for injection for treating wet age-related macular degeneration. 2013. https://www.nice.org.uk/guidance/ta294. Accessed July 17, 2021.
   Google Scholar
• Androudi S, Dastiridou A, Pharmakakis N, et al. Guidelines for the management of wet age-related macular degeneration: recommendations from a panel of Greek experts. Adv Ther. 2016;33(5):715–726. doi:10.1007/s12325-016-0332-7.
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144–1167. doi:10.1136/bjophthalmol-2014-305702.
   PubMed Web of Science ®Google Scholar
• Koh A, Lim TH, Au Eong KG, et al. Optimising the management of choroidal neovascularisation in Asian patients: consensus on treatment recommendations for anti-VEGF therapy. Singapore Med J. 2011;52(4):232–240.
   PubMed Web of Science ®Google Scholar
• Cruess AF, Berger A, Colleaux K, et al. Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration. Can J Ophthalmol. 2012;47(3):227–235. doi:10.1016/j.jcjo.2012.03.007.
   PubMed Web of Science ®Google Scholar
• Freund KB, Korobelnik JF, Devenyi R, et al. Treat-and-extend regimens with anti-VEGF agents in retinal diseases: a literature review and consensus recommendations. Retina. 2015;35(8):1489–1506. doi:10.1097/IAE.0000000000000627.
   PubMed Web of Science ®Google Scholar
• Lanzetta P, Loewenstein A, Vision Academy Steering C. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Arch Clin Exp Ophthalmol. 2017;255(7):1259–1273. doi:10.1007/s00417-017-3647-4.
   Web of Science ®Google Scholar
• Tuuminen R, Tuulonen A, Kaarniranta K. The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration. Acta Ophthalmol. 2017;95(7):649–650. doi:10.1111/aos.13341.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Comprehensive adult medical eye evaluation preferred practice pattern. 2015. https://www.aaojournal.org/article/S0161-6420(15)01269-5/pdf. Accessed July 17, 2021.
   Google Scholar
• Nikkhah H, Karimi S, Ahmadieh H, et al. Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: clinical practice guideline. J Ophthalmic Vis Res. 2018;13(2):158–169. doi:10.4103/jovr.jovr_50_18.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Williams M, Group AMDG. The royal college of ophthalmologists guidelines on AMD: executive summary. Eye. 2013;27(12):1429–1431. doi:10.1038/eye.2013.233.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Age-related macular degeneration overview. 2019. https://pathways.nice.org.uk/pathways/age-related-macular-degeneration. Accessed July 17, 2021.
   Google Scholar
• LIywodraeth Cymru Welsh Government. Wales Eye Healthcare Service - Eye Health Examinations Wales (EHEW). 2014. https://gov.wales/eye-health-examinations-wales-ehew-manual-and-protocols-whc-201400714. Accessed July 19, 2021.
   Google Scholar
• The Royal Australian and New Zealand colleage of Ophthalmologists. NZ National guidelines for management of neovascular AMD. 2018. https://ranzco.edu/wp-content/uploads/2018/11/National-Guidelines-for-management-of-neovascular-AMD-RANZCO-2-1.pdf. Accessed July 19, 2021.
   Google Scholar
• The royal college of ophthalmologists. Commissioning better eye care: age-related macular degeneration. 2013. https://www.evidence.nhs.uk/document?id=1617896&returnUrl=search%3Fq%3Deye%2Bcare&q=eye+care. Accessed July 19, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Age-related macular degeneration. 2018. https://www.nice.org.uk/guidance/ng82. Accessed July 17, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Macular degeneration - age-related. 2016. https://www.nice.org.uk/search?pa=1&ps=15&q=Macular+degeneration. Accessed July 17, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Miniature lens system implantation for advanced age-related macular degeneration. 2016. https://www.nice.org.uk/guidance/ipg565/resources/miniature-lens-system-implantation-for-advanced-agerelated-macular-degeneration-pdf-1899872049404869. Accessed July 17, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Limited macular translocation for wet age-related macular degeneration. 2010. https://www.nice.org.uk/guidance/ipg339. Accessed July 17, 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Epiretinal brachytherapy for wet age-related macular degeneration. 2011. https://www.nice.org.uk/guidance/ipg415. Accessed July 17, 2021.
   Google Scholar
• Bakri SJ, Thorne JE, Ho AC, et al. Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(1):55–63. doi:10.1016/j.ophtha.2018.07.028.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:CD005139. doi:10.1002/14651858.CD005139.pub4.
   PubMedGoogle Scholar
• Velilla S, Garcia-Medina JJ, Garcia-Layana A, et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013;2013:895147. doi:10.1155/2013/895147.
   PubMed Web of Science ®Google Scholar
• Detaram HD, Joachim N, Liew G, et al. Smoking and treatment outcomes of neovascular age-related macular degeneration over 12 months. British Journal of Ophthalmology. 2020;104(7):893–898. doi:10.1136/bjophthalmol-2019-314849.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Flood VM, Kifley A, Liew G, Mitchell P, Sørensen TL. Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years. PloS one. 2015;10(3):e0122548. doi:10.1371/journal.pone.0122548.
   PubMed Web of Science ®Google Scholar
• Swanson MW. Smoking deception and age-related macular degeneration. Optom Vis Sci. 2014;91(8):865–871. doi:10.1097/OPX.0000000000000315.
   PubMed Web of Science ®Google Scholar
• Evans JR, Igwe C, Jackson TL, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2020;8:CD004004. doi:10.1002/14651858.CD004004.pub4.
   PubMedGoogle Scholar
• Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2005;(4):CD002030. doi:10.1002/14651858.CD002030.pub2.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence (NICE). Macular translocation with 360° retinotomy for wet age-related macular degeneration. 2010. https://www.nice.org.uk/guidance/ipg340. Accessed July 17, 2021.
   Google Scholar
• Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina. 2001;21(4):293–303. doi:10.1097/00006982-200108000-00001.
   PubMed Web of Science ®Google Scholar
• Lai JC, Lapolice DJ, Stinnett SS, et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol. 2002;120(10):1317–1324. doi:10.1001/archopht.120.10.1317.
   PubMedGoogle Scholar
• Eandi CM, Giansanti F, Virgili G. Macular translocation for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2008;(4):CD006928. doi:10.1002/14651858.CD006928.pub2.
   PubMedGoogle Scholar
• Williams MA, McKay GJ, Chakravarthy U. Complement inhibitors for age-related macular degeneration. Cochrane Database Syst Rev. 2014;(1):CD009300. doi:10.1002/14651858.CD009300.pub2.
   PubMedGoogle Scholar
• Reddy U, Kryzstolik M. Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2006;(1):CD005138. doi:10.1002/14651858.CD005138.pub2.
   PubMedGoogle Scholar
• Yeong JL, Loveman E, Colquitt JL, Royle P, Waugh N, Lois N. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration. Cochrane Database Syst Rev. 2020;12:CD013154. doi:10.1002/14651858.CD013154.pub2.
   PubMedGoogle Scholar
• Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev. 2016;(8):CD006927. doi:10.1002/14651858.CD006927.pub5.
   PubMedGoogle Scholar
• Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2017;7:CD000254. doi:10.1002/14651858.CD000254.pub4.
   PubMed Web of Science ®Google Scholar
• Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2017;7:CD000253. doi:10.1002/14651858.CD000253.pub4.
   PubMedGoogle Scholar
• Age-related eye disease study 2 research. G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. Jama. 2013;309(19):2005–2015. doi:10.1001/jama.2013.4997.
   PubMed Web of Science ®Google Scholar